3 recruiting, 3 unknown, 2 not yet recruiting, 1 completed. 10 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Recruiting 3, Unknown 3, Not yet recruiting 2, Completed 1, Terminated 1 |
| Phase 3 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Microwave ablation: new trials by email Literature Review of Microwave ablation trials Research Report on Microwave ablation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases 1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water, 1.0% IP-001 for Injection, a 1 mg/mL solution of IP-001 in water., Microwave (thermal) tumor ablation - Colorectal Cancer (CRC), Colon Cancer Liver Metastases | Phase 2 / Phase 3 | Not yet recruiting | Immunophotonics, Inc. | 717 | 2026-05-01 | 2026-01-07 |
| Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure Tislelizumab, Docetaxel, Microwave ablation - NSCLC (Non-small Cell Lung Cancer), NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 2 | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 20 | 2026-05-01 | 2026-04-14 |
| A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors Adebrelimab, Apatinib, microwave ablation - Solid Tumor | Phase 2 | Not yet recruiting | Beidahuang Industry Group General Hospital | 60 | 2024-08-05 | 2024-08-05 |
| Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial Stereotactic Ablative Radiotherapy, Resection, Microwave Ablation - Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 | Phase 2 | Recruiting | Alliance for Clinical Trials in Oncology | 146 | 2023-10-09 | 2026-11-03 |
| Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung Cancer Almonertinib plus microwave ablation - Advanced Non Small Cell Lung Cancer | Phase 2 | Unknown | Qianfoshan Hospital | 234 | 2022-01-01 | 2021-09-05 |
| Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer Microwave Ablation, Camrelizumab, Breast Surgery - Breast Cancer | Phase 2 | Completed | The First Affiliated Hospital with Nanjing Medical University | 60 | 2021-03-25 | 2024-01-05 |
| Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial Microwave ablation plus Camrelizumab, Microwave ablation - Multiple Primary Lung Cancer | Phase 2 | Recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 146 | 2021-03-21 | 2021-09-23 |
| Microwave Ablation of Primary and Secondary Lung Malignancies Microwave ablation - Lung Neoplasms, Neoplasm Metastasis | Phase 1 / Phase 2 | Unknown | University of Calgary | 35 | 2020-05-01 | 2020-11-09 |
| Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy Microwave ablation, Cryoablation, Radiofrequency ablation - Osteosarcoma, Sarcoma | Phase 2 | Terminated | Washington University School of Medicine | 9 | 2014-02-03 | 2018-09-19 |
| Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions microwave ablation - Neoplasm of Breast | Phase 2 / Phase 3 | Unknown | Chinese PLA General Hospital | 500 | 2012-12-01 | 2016-11-23 |
Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Colorectal Neoplasms (2) · Neoplasm Metastasis (2) · Lung Neoplasms (1) · Neoplasms (1) · Osteosarcoma (1) · Rectal Neoplasms (1) · Sarcoma (1)
Alliance for Clinical Trials in Oncology (1) · Beidahuang Industry Group General Hospital (1) · Chinese PLA General Hospital (1) · Immunophotonics, Inc. (1) · Qianfoshan Hospital (1) · Shanghai Pulmonary Hospital, Shanghai, China (1) · The First Affiliated Hospital with Nanjing Medical University (1) · Tianjin Medical University Cancer Institute and Hospital (1) · University of Calgary (1) · Washington University School of Medicine (1)
China (5) · Canada (2) · United States (2)
Brian Van Tine, M.D., Ph.D. (1) · Chang Chen, Dr (1) · Diane M Beatty, PhD (1) · Ping Liang, Doctor (1) · Stefan J Przybojewski, MB ChB (1)
PMID 29487221, PMID 31179781, PMID 32356159, PMID 36652155, PMID 38350888, PMID 38417440
2025 (1)